Latest News
- Details
November's Paper of the Month investigates factors contributing to the difference in higher locoregional recurrence (LRR) observed after total neoadjuvant treatment (TNT) versus chemoradiotherapy in the RAPIDO trial.
- Details
October’s Paper of the Month study adds to the data on the effect of structured exercise after adjuvant chemotherapy on disease-free survival in patients with stage II or III colon cancer.
- Details
ESCP offered 3-month Functional Disorder Fellowships and 6-month Robotics Fellowships for 2023-2024, as well as three Travelling Fellowships. Fellows report here on their experiences.
- Details
The deadline for applications to take the next EBSQ Coloproctology Examination is 20 November 2025.
- Details
The 4th ESCP Masterclass was successfully held on 27 August 2025 in Cairo, Egypt, drawing an impressive attendance of 132 participants, including leading international experts, regional surgeons, and trainees.
- Details
September's Paper of the Month looks at a double-blind, randomised, placebo-controlled trial involving patients with stage I, II, or III rectal cancer or stage II or III colon cancer with somatic alterations in PI3K pathway genes.
- Details
Inspiration, preparation, and collaboration on the road to EBSQ success
- Details
August's Paper of the Month study adds to the data looking at associations between the gut microbiome and colorectal cancer (CRC).
- Details
This month's paper assessed the noninferior results of chemoradiotherapy and local excision compared with Total Mesorectal Excision in T2-T3ab, N0, M0 Rectal Cancer.
- Details
At this year’s ACPGBI Annual Meeting, many from the colorectal community gathered to honour the remarkable legacy of Professor Neil Smart. His dedication to colorectal surgery, unwavering kindness and commitment to patients will always be remembered.